Search
for
Sort by
Research 511–540 of 1000+
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Pellagra and anorexia nervosa: a case report
- Polyethylene-Glycol-Ornamented Small Intestinal Submucosa Biosponge for Skin Tissue Engineering
- A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- The Role of Cytochrome P-450 in Dermatology
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- The most common pediatric and adult dermatology patient complaints in a month of the COVID‐19 pandemic in Turkey
- Follicular Transplantation, Microneedling, and Adjuvant Narrow-band Ultraviolet-B Irradiation as Cost-Effective Regimens for Palmar-Plantar Vitiligo: A Pilot Study
- Assessment, Treatment, and Prevention Strategies for Hair-Thread Tourniquet Syndrome in Infants
- Dermatological problems of asylum seekers arriving on boats: A case report from Australia and a brief review
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Darier Sign: A Historical Note
- Efficacy and Safety of an Autologous Micrografting Procedure for Management of Striae Distensae in Women
- Alopecia areata; combination therapy with isotretinoin (0.05%) gel and minoxidil (2%) solution
- Organizadores e cortadores de comprimidos: riscos e restrições ao uso
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Le gène<i>hairless</i>de la souris
- Healthy Skin for Women: A Review of Common Conditions and Therapies
- Impact of Laser Therapy on the Quality of Life in Women Living With Polycystic Ovary Syndrome-Associated Hirsutism: An Observational Study
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- Ageing skin, part 1: normal ageing
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Can male-pattern baldness be prevented?
- Unlocking Dithranol’s Potential: Advanced Drug Delivery Systems for Improved Pharmacokinetics
- Nanofibers: An Effective Biomedical Tool for Burn Management
- Serum levels of ifn-γ, complement component c3 c4 and vitamin d3 in the prognosis of patients with alopecia areata prospective teachers
- Complementary evolution of coding and noncoding sequence underlies mammalian hairlessness
- A Permanent Hair Loss in a Patient with Hypersensitivity to Intralesional Triamcinolone Injection